Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of two regimens containing tacrolimus and minimal steroids
together with either monoclonal anti-IL2R antibodies (daclizumab) or mycophenolate mofetil.